<SEC-DOCUMENT>0001213900-20-000155-index.html : 20200103 <SEC-HEADER>0001213900-20-000155.hdr.sgml : 20200103 <ACCEPTANCE-DATETIME>20200103163039 ACCESSION NUMBER: 0001213900-20-000155 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200102 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 20505929 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>f8k010220_soligenixinc.htm <DESCRIPTION>FORM 6-K <TEXT> Document 1 - file: f8k010220_soligenixinc.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>f8k010220ex10-1_soligenixinc.htm <DESCRIPTION>SECOND AMENDMENT TO EMPLOYMENT AGREEMENT DATED AS OF JANUARY 2, 2020, BETWEEN SOLIGENIX, INC. AND CHRISTOPHER J. SCHABER, PHD <TEXT> Document 2 - file: f8k010220ex10-1_soligenixinc.htm
</DOCUMENT> </SEC-DOCUMENT>